Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Ferris, Robert L., Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin J., Kasper, Stefan, Vokes, Everett E., Even, Caroline, Worden, Francis,Том:
81
Мова:
english
Журнал:
Oral Oncology
DOI:
10.1016/j.oraloncology.2018.04.008
Date:
June, 2018
Файл:
PDF, 276 KB
english, 2018
File converter
Більше результатів пошуку
More benefits 
